Scedosporium/Pseudallescheria infections.

Semin Respir Crit Care Med

Fred Hutchinson Cancer Research Center, University of Washington, Seattle, Washington, USA.

Published: April 2004

The genus Scedosporium comprises a group of filamentous fungi found ubiquitously in the environment. The two major human pathogens within this genus are S. apiospermum-the asexual state of Pseudallescheria boydii-and S. prolificans. Both histologically resemble Aspergillus species, with hyphae that are septated and branching at acute angles. Although Scedosporium infections can occur in immunocompetent persons, the overall incidence has increased over the last decade as a consequence of improved diagnostics and a growing immunosuppressed population (e.g., transplant, malignancy, acquired immunodeficiency syndrome). These organisms can cause systemic infection in immunocompromised hosts manifested as sinopulmonary, central nervous system, osteoarticular, ocular, endovascular, and lymphocutaneous disease. Dissemination may occur hematogenously or contiguously, with high associated mortality (>75%). Scedosporium species are known to be largely resistant to traditional antifungals such as amphotericin B; however, treatment with newer triazoles, such as voriconazole, appears to be more efficacious.

Download full-text PDF

Source
http://dx.doi.org/10.1055/s-2004-824901DOI Listing

Publication Analysis

Top Keywords

scedosporium/pseudallescheria infections
4
infections genus
4
genus scedosporium
4
scedosporium comprises
4
comprises group
4
group filamentous
4
filamentous fungi
4
fungi ubiquitously
4
ubiquitously environment
4
environment major
4

Similar Publications

Metagenomics Applied to the Respiratory Mycobiome in Cystic Fibrosis.

Mycopathologia

September 2024

Unité de Parasitologie-Mycologie, Département de Prévention, Diagnostic et Traitement des Infections, Hôpitaux Universitaires Henri Mondor, Assistance Publique des Hôpitaux de Paris (APHP), Créteil, France.

Cystic fibrosis (CF) is a genetic disorder characterized by chronic microbial colonization and inflammation of the respiratory tract (RT), leading to pulmonary exacerbation (PEx) and lung damage. Although the lung bacterial microbiota has been extensively studied, the mycobiome remains understudied. However, its importance as a contributor to CF pathophysiology has been highlighted.

View Article and Find Full Text PDF

An increase is observed in the frequency and diversity of fungal infections in the world and in our country. Improving the quality of patient care in infections due to rare moulds depends on early diagnosis and appropriate treatment. Raising awareness about these infections will facilitate taking the necessary steps for diagnosis and treatment in similar cases.

View Article and Find Full Text PDF

Multilocus Sequence Typing Reveals Extensive Genetic Diversity of the Emerging Fungal Pathogen .

Front Cell Infect Microbiol

January 2022

Molecular Mycology Research Laboratory, Centre for Infectious Diseases and Microbiology, Faculty of Medicine and Health, Sydney Medical School, Westmead Clinical School, Sydney Institute for Infectious Diseases, Westmead Hospital-Research and Education Network, Westmead Institute for Medical Research, University of Sydney, Sydney, NSW, Australia.

spp. are the second most prevalent filamentous fungi after spp. recovered from cystic fibrosis (CF) patients in various regions of the world.

View Article and Find Full Text PDF

Efficacy of Olorofim against Systemic Scedosporiosis and Lomentosporiosis.

Antimicrob Agents Chemother

September 2021

Molecular Microbiology Section, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.

Clinically relevant members of the / species complex and Lomentospora prolificans are generally resistant against currently available systemic antifungal agents , and infection due to these species is difficult to treat. We studied the efficacy of a new fungicidal agent, olorofim (formerly F901318), against scedosporiosis and lomentosporiosis in neutropenic animals. Cyclophosphamide-immunosuppressed CD-1 mice infected by Scedosporium apiospermum, Pseudallescheria boydii (Scedosporium boydii), and Lomentospora prolificans were treated by intraperitoneal administration of olorofim (15 mg/kg of body weight every 8 h for 9 days).

View Article and Find Full Text PDF

Voriconazole is a second-generation triazole derived from fluconazole, having an enhanced antifungal spectrum, compared with older triazoles. It is the drug of choice for treatment of invasive aspergillosis and many Scedosporium/Pseudallescheria Fusarium infections. Voriconazole is available in both intravenous and oral formulations.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!